BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5336629)

  • 1. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria.
    Chin W; Coatney GR; King HK
    Am J Trop Med Hyg; 1967 Jan; 16(1):13-4. PubMed ID: 5336629
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
    Chin W; Lunn JS; Buxbaum J; Contacos PG
    Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of the drug-resistant malarias.
    Schmidt LH
    Annu Rev Microbiol; 1969; 23():427-54. PubMed ID: 4901983
    [No Abstract]   [Full Text] [Related]  

  • 4. The problem of drug-resistant malaria.
    Clyde DF
    Am J Trop Med Hyg; 1972 Sep; 21(5):736-43. PubMed ID: 4561521
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyresistant malaria in Gurkha soldiers returning from Papua New Guinea: treatment and prevention.
    Henderson A; Simon J; Melia W; Navein J; McCallum J
    J R Army Med Corps; 1986 Feb; 132(1):37-41. PubMed ID: 3517314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the chemotherapy of malaria.
    Pinder RM
    Prog Med Chem; 1971; 8(2):231-316. PubMed ID: 4947769
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of new antimalarial drugs.
    Powell RD
    Am J Trop Med Hyg; 1972 Sep; 21(5):744-8. PubMed ID: 4561522
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax].
    Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F
    Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of malaria.
    Rozman RS
    Annu Rev Pharmacol; 1973; 13():127-52. PubMed ID: 4576886
    [No Abstract]   [Full Text] [Related]  

  • 10. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of malaria.
    Talukdar B
    Indian Pediatr; 1986 May; 23(5):371-5. PubMed ID: 3527970
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN.
    COATNEY GR; CONTACOS PG; LUNN JS; KILPATRICK JW; ELDER HA
    Am J Trop Med Hyg; 1963 Jul; 12():504-8. PubMed ID: 14044760
    [No Abstract]   [Full Text] [Related]  

  • 14. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.
    Schmidt LH; Rossan RN
    Antimicrob Agents Chemother; 1984 Nov; 26(5):611-42. PubMed ID: 6393864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of drugs in a malaria program.
    Bruce-Chwatt LJ
    Am J Trop Med Hyg; 1972 Sep; 21(5):731-5. PubMed ID: 5074690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tolerance of Plasmodium falciparum to pyrimethamine, proguanil and C.I. 501 in the Niayes region (Senegal)].
    Michel R; Pene P; Courtney KO
    Bull Soc Pathol Exot Filiales; 1966; 59(5):797-803. PubMed ID: 6014281
    [No Abstract]   [Full Text] [Related]  

  • 17. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.
    Chin W; Contacos PG; Coatney GR; Jeter MH; Alpert E
    Am J Trop Med Hyg; 1967 Sep; 16(5):580-4. PubMed ID: 4861322
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 20. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.